NanoCellect Biomedical Announces Distribution to Korea
SAN DIEGO (May 9, 2019) – NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced the selection of Seoul-based DAON BioSciences as exclusive distributor in the South Korea market. DAON is a leading distributor of instruments, reagents and software to the Korean biotechnology research market.
“Korea is a key area of growth for NanoCellect, and working with DAON was an obvious choice for us,” said Chris Neary, CEO of NanoCellect. “We believe that our products complement their current portfolio and will greatly enhance their ability to improve the research workflows for their customers. We were also impressed with the positive feedback from their existing partners and customers in Korea, describing the high level of technical support and professionalism from the team at DAON.”
“We are pleased to be adding NanoCellect’s cell sorting solutions to our portfolio,” said Sujin Kim, CEO at DAON. “NanoCellect’s WOLF platform will enable our customers to significantly advance their research by providing gentle cell sorting in sterile microfluidic cartridges. The WOLF platform will address an unmet need of many of our research customers, advancing single cell genomics and cloning applications in Korea.
About DAON BioSciences Inc.
DAON BioSciences Inc. is a leading distributor of instrumentation, reagents and software for the Korean biotechnology research market, with strong business performance and qualified technical support. DAON BioSciences focuses on creating practical demand in its territory and building close relationships through providing premier high-tech products for multiple applications.
About NanoCellect Biomedical
NanoCellect is a life science tools company that develops and manufactures innovative solutions for cell analysis and sorting based on microfluidic technology. NanoCellect’s WOLF Cell Sorter and N1 single-cell plate dispenser provide gentle sorting to maintain cell viability. The WOLF platform is used in a growing list of application areas including antibody discovery, cell line development, genomic sample preparation, CRISPR genomic editing and plant and animal genomics. Founded in 2009, NanoCellect headquarters are in San Diego.
# # #